Adrenocortical carcinoma is a rare malignancy. A virilizing adrenocortical carcinoma is even more unique of a diagnosis. In this report, we present a rare case of this uncommon tumor with an interesting presentation, clearly documented physical exam changes over a span of at least 8 years, and a technically challenging case. We also briefly review the management of adrenocortical carcinoma. The tumor was successfully resected with no planned adjuvant treatment at this time. The patient had recurrence of menstrual cycle post-operatively and required no steroid supplementation.
BedroseSDaherMAltameemiL, et al.Adjuvant therapy in adrenocortical carcinoma: reflections and future directions. Cancers. 2020;12(2):E508. doi:10.3390/cancers12020508
2.
ElseTKimACSabolchA, et al.Adrenocortical carcinoma. Endocr Rev. 2014;35(2):282–326. doi:10.1210/er.2013-1029
3.
FassnachtMLibéRKroissM, et al.Adrenocortical carcinoma: a clinician’s update. Nat Rev Endocrinol. 2011;7(6):323–335. doi:10.1038/nrendo.2010.235
